Therapeutic effect of etanercept in anti-laminin 5 (laminin 332) mucous membrane pemphigoid

Int J Dermatol. 2011 Sep;50(9):1129-31. doi: 10.1111/j.1365-4632.2010.04707.x.

Authors

Sarah Schulz¹, Dirk Deuster, Enno Schmidt, Gisela Bonsmann, Stefan Beissert

Affiliation

¹ Department of Dermatology, University of Münster, Münster, Germany.

PMID: 22126878
DOI: 10.1111/j.1365-4632.2010.04707.x

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Autoantibodies / blood*
Cell Adhesion Molecules / immunology*
Etanercept
Humans
Immunoglobulin G / therapeutic use*
Immunosuppressive Agents / therapeutic use*
Kalinin
Male
Middle Aged
Pemphigoid, Benign Mucous Membrane / drug therapy*
Pemphigoid, Benign Mucous Membrane / immunology
Receptors, Tumor Necrosis Factor / therapeutic use*

Substances

Autoantibodies
Cell Adhesion Molecules
Immunoglobulin G
Immunosuppressive Agents
Receptors, Tumor Necrosis Factor
Etanercept